Increase in Invasive Streptococcus Pneumoniae Infections in Children with Sickle Cell Disease since Pneumococcal Conjugate Vaccine Licensure (vol 158, pg 505, 2011)

被引：0
|
作者：
McCavit
机构：
来源：
JOURNAL OF PEDIATRICS | 2011年 / 158卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：867 / 867
页数：1
相关论文
共 50 条
  • [21] Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature
    Oligbu, Godwin
    Fallaha, Mohammad
    Pay, Leon
    Ladhani, Shamez
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 743 - 751
  • [22] Serum opsonic activity for Streptococcus pneumoniae types 6B and 14 in infants with sickle cell disease after immunization with pneumococcal protein conjugate vaccine
    Nowak-Wegrzyn, AH
    Winkelstein, JA
    Stover, BM
    Swift, AJ
    Lederman, HM
    PEDIATRIC RESEARCH, 1999, 45 (04) : 11A - 11A
  • [23] Serum Opsonic Activity for Streptococcus pneumoniae Types 6B and 14 in Infants with Sickle Cell Disease after Immunization with Pneumococcal Protein Conjugate Vaccine
    Anna H Nowak-Wegrzyn
    Jerry A Winkelstein
    Beth M Stover
    Andrea J Swift
    Howard M Lederman
    Pediatric Research, 1999, 45 : 11 - 11
  • [24] Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure
    McCavit, Timothy L.
    Xuan, Lei
    Zhang, Song
    Flores, Glenn
    Quinn, Charles T.
    PEDIATRIC BLOOD & CANCER, 2012, 58 (06) : 945 - 949
  • [25] Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation
    dos Santos, Silvia R.
    Passadore, Lilian F.
    Takagi, Elizabeth H.
    Fujii, Cristiane M.
    Yoshioka, Cristina R. M.
    Gilio, Alfredo E.
    Martinez, Marina B.
    VACCINE, 2013, 31 (51) : 6150 - 6154
  • [26] Invasive Streptococcus pneumoniae infections in children in Kamikawa and Soya subprefecture, Hokkaido, Japan, 2000-2010, before the introduction of the 7-valent pneumococcal conjugate vaccine
    Sakata, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (06) : 799 - 802
  • [27] Invasive Pneumococcal Disease in Young Children Before Licensure of 13-Valent Pneumococcal Conjugate Vaccine-United States, 2007 (Reprinted from MMWR, vol 59, pg 253-257, 2010)
    Farley, M. M.
    Petit, S.
    Harrison, L. H.
    Hollick, R. A.
    Zansky, S. M.
    Gershman, K.
    Schaffner, W.
    Barnes, B.
    McMinn, T.
    Thomas, A.
    Kirley, P. D.
    Baumbach, J.
    Lexau, C.
    Henry, J.
    Beall, B.
    Whitney, C. G.
    Moore, M.
    Nuorti, J. P.
    Rosen, J. B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (20): : 2024 - 2026
  • [28] Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children
    De Wals, Philippe
    VACCINE, 2018, 36 (37) : 5495 - 5496
  • [29] Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae
    Lin, Haiying
    Peng, Yonghui
    Lin, ZiLin
    Zhang, Shuangling
    Guo, Yanghao
    MICROBIAL PATHOGENESIS, 2015, 83-84 : 35 - 40
  • [30] Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota, Colombia
    Parra, Eliana L.
    De La Hoz, Fernando
    Diaz, Paula L.
    Sanabria, Olga
    Elena Realpe, Maria
    Moreno, Jaime
    VACCINE, 2013, 31 (37) : 4033 - 4038
12345